Ignite Creation Date:
2024-05-06 @ 9:25 AM
Last Modification Date:
2024-10-26 @ 12:13 PM
Study NCT ID:
NCT02971748
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-19
First Post:
2016-11-21
Brief Title:
Pembrolizumab in Treating Patients With Hormone Receptor Positive Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Anatomic Stage IIIB Breast Cancer AJCC v8 |
| Anatomic Stage IIIC Breast Cancer AJCC v8 |
| Breast Inflammatory Carcinoma |
| Prognostic Stage IIIB Breast Cancer AJCC v8 |
| Prognostic Stage IIIC Breast Cancer AJCC v8 |
Keywords: